Close

Cubist Pharmaceuticals, Inc. (CBST) Tops Q1 EPS by 1c

April 18, 2012 4:00 PM EDT
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q1 EPS of $0.45, $0.01 better than the analyst estimate of $0.44. Revenue for the quarter came in at $211.7 million versus the consensus estimate of $210.54 million.

For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings